An in-depth look to NOVONESIS (NOVOZYMES A/S) B operating, investing, and financing activities

NSIS_B free cash flow for H2 24 is 2.15 B DKK. For 2024, NSIS_B free cash flow was 5.08 B DKK and operating cash flow was 7.61 B DKK.